We work with top collaborators around the world to discover and validate our tests, and continue active research programs focused on understanding how these imbalances cause disease.
These interactions exert their effects within the body at the molecular level, without any noticeable symptoms. But they can occur, accumulating over many years.
Eventually, the functions of cells become affected. This leads to compromises in physiological functions and clinically-noticeable outcomes such as tumour growth, onset of dementia, or other symptoms.
Our research has identified several metabolic system imbalances that correlate with the presence of several diseases including colorectal cancer, pancreatic cancer and Alzheimer's disease. We believe these imbalances begin well before, and play a role in, the development of disease.
Detecting people among the general population with these pre-symptomatic metabolic imbalances is the fundamental concept of our tests. These individuals can then more closely monitor their heath, adopt lifestyle changes to reduct their risk, or could be candidates for pharmacologically correcting the imbalance.